Betamethasone dipropionate and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Betamethasone dipropionate (betamethasone dipropionate) and Tacrolimus (tacrolimus). Common drug interactions include arterial occlusive disease among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Betamethasone dipropionate and Tacrolimus. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Betamethasone dipropionate?

Betamethasone dipropionate has active ingredients of betamethasone dipropionate. It is often used in psoriasis. eHealthMe is studying from 3,318 Betamethasone dipropionate users. Check the latest studies of Betamethasone dipropionate.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,161 Tacrolimus users. Check the latest studies of Tacrolimus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

100 people who take Betamethasone dipropionate and Tacrolimus together, and have interactions are studied.

Betamethasone dipropionate and Tacrolimus drug interactions.

What are the common drug interactions of Betamethasone Dipropionate and Tacrolimus, by gender? *:

female:

Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood immunoglobulin g increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac disorder
Chapped lips (cracking, fissuring, and peeling of the skin f lip)
Cheilitis (infection of lips)
Chest pain
Chills (felling of cold)
Conjunctivitis (pink eye)

male:

Drug ineffective
Pain
Corneal endotheliitis (an immune response within the endothelium in blood vessels)
Disease progression
Gait disturbance
Obesity (having too much body fat)
Pneumonia
Pruritus (severe itching of the skin)
Rash
Rhinorrhoea (watery mucus discharge from the nose)

What are the common drug interactions of Betamethasone Dipropionate and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

Cushing's syndrome (obesity, a rounded face, increased fat)
Blood cortisol decreased
Coarctation of the aorta (narrowing of the part of aorta)
Growth retardation (delayed growth)
Hypercorticoidism (excessive secretion of one or more steroid hormones of the adrenal cortex)
Hypothalamo-pituitary disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

2-9:

Food allergy
Discomfort
Drug ineffective
Pruritus (severe itching of the skin)
Rash
Sleep disorder

10-19:

Cushing's syndrome (obesity, a rounded face, increased fat)
Disease progression
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Gait disturbance
Ligament sprain (ligament stretched)
Obesity (having too much body fat)
Pain
Alopecia (absence of hair from areas of the body)
Bone pain

20-29:

Drug ineffective
Discomfort
Injection site pain
Pruritus (severe itching of the skin)
Rash
Constipation
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Erythema (redness of the skin)
Injection site reaction

30-39:

Dry eye (lack of adequate tears)
Eye pruritus (eye itching)
Food allergy
Injection site swelling
Lip dry
Skin fissures (a crack in the skin)
Skin haemorrhage (bleeding into skin)
Sleep disorder
Visual impairment
Dizziness

40-49:

Alopecia (absence of hair from areas of the body)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Drug ineffective
Lung disorder (lung disease)
Oropharyngeal pain
Pain
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Skin disorder (skin disease)

50-59:

Drug ineffective
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Dizziness
Dysplasia (enlargement of an organ or tissue)
Headache (pain in head)
Pruritus (severe itching of the skin)
Rash
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Rhinorrhoea (watery mucus discharge from the nose)
Therapeutic response decreased (less preventive response)

60+:

Drug ineffective
Diarrhoea
Blepharitis (chronic inflammation of the eyelid)
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
Cardiac failure
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Colitis (inflammation of colon)
Dental caries
Headache (pain in head)
Injection site pain

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 34 people, 34.00%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 6 people, 6.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.00%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Betamethasone dipropionate and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously